Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea
· Delayed Price · Currency is KRW 5,410.00
+100.00 (1.88%)
Mar 10, 2026, 10:59 AM KST
Kyongbo Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 126,945 | 148,701 | 200,579 | 239,069 | 256,999 | 390,877 | Upgrade
|
| Market Cap Growth | -14.22% | -25.86% | -16.10% | -6.98% | -34.25% | 97.94% | Upgrade
|
| Enterprise Value | 246,427 | 236,571 | 278,339 | 290,819 | 317,767 | 437,346 | Upgrade
|
| Last Close Price | 5310.00 | 6166.38 | 8261.77 | 9788.34 | 10462.95 | 15838.36 | Upgrade
|
| PE Ratio | 53.71 | 32.05 | 67.44 | 391.54 | - | 41.56 | Upgrade
|
| PS Ratio | 0.50 | 0.62 | 0.93 | 1.22 | 1.51 | 1.82 | Upgrade
|
| PB Ratio | 0.87 | 1.02 | 1.39 | 1.66 | 1.76 | 2.51 | Upgrade
|
| P/TBV Ratio | 0.90 | 1.05 | 1.43 | 1.70 | 1.81 | 2.56 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 556.60 | 44.73 | Upgrade
|
| P/OCF Ratio | 18.38 | 997.21 | 41.41 | 23.61 | 14.30 | 18.80 | Upgrade
|
| EV/Sales Ratio | 0.98 | 0.99 | 1.29 | 1.48 | 1.86 | 2.03 | Upgrade
|
| EV/EBITDA Ratio | 11.05 | 10.35 | 16.14 | 21.82 | 51.82 | 20.58 | Upgrade
|
| EV/EBIT Ratio | 26.11 | 22.63 | 50.20 | 208.82 | - | 50.49 | Upgrade
|
| EV/FCF Ratio | -8.23 | - | - | - | 688.22 | 50.05 | Upgrade
|
| Debt / Equity Ratio | 0.85 | 0.63 | 0.53 | 0.45 | 0.39 | 0.41 | Upgrade
|
| Debt / EBITDA Ratio | 6.58 | 4.00 | 4.40 | 4.84 | 9.23 | 2.98 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 122.55 | 7.24 | Upgrade
|
| Net Debt / Equity Ratio | 0.82 | 0.58 | 0.49 | 0.40 | 0.36 | 0.27 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.34 | 3.73 | 4.09 | 4.30 | 8.53 | 1.99 | Upgrade
|
| Net Debt / FCF Ratio | -3.99 | -6.80 | -14.56 | -20.86 | 113.26 | 4.84 | Upgrade
|
| Asset Turnover | 0.85 | 0.87 | 0.85 | 0.82 | 0.70 | 0.88 | Upgrade
|
| Inventory Turnover | 1.78 | 1.94 | 2.40 | 2.65 | 2.27 | 2.63 | Upgrade
|
| Quick Ratio | 0.39 | 0.44 | 0.53 | 0.61 | 0.59 | 0.79 | Upgrade
|
| Current Ratio | 0.95 | 1.15 | 1.15 | 1.22 | 1.25 | 1.47 | Upgrade
|
| Return on Equity (ROE) | 1.63% | 3.19% | 2.07% | 0.42% | -4.97% | 6.16% | Upgrade
|
| Return on Assets (ROA) | 1.25% | 2.38% | 1.37% | 0.36% | -1.69% | 2.21% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.00% | 4.43% | 2.67% | 0.70% | -3.34% | 2.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.00% | 6.90% | 3.70% | 1.00% | -4.50% | 5.40% | Upgrade
|
| Earnings Yield | 1.86% | 3.12% | 1.48% | 0.26% | -2.92% | 2.41% | Upgrade
|
| FCF Yield | -23.58% | -8.44% | -2.42% | -1.15% | 0.18% | 2.24% | Upgrade
|
| Payout Ratio | 50.51% | 25.77% | 40.19% | 195.77% | - | 25.42% | Upgrade
|
| Buyback Yield / Dilution | -0.32% | 0.34% | -2.14% | 1.62% | 0.25% | -0.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.